Insmed Stock (NASDAQ: INSM) stock price, news, charts, stock research, profile.
Open | $67.25 |
Close | $67.00 |
Volume / Avg. | 4.80M / 3.34M |
Day Range | 65.14 - 67.50 |
52 Wk Range | 19.68 - 70.65 |
Market Cap | $10.93B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 76 |
Short Interest | 7.19% |
Days to Cover | 3.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Other companies in Insmed’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
There is no analysis for Insmed.
Insmed has a consensus price target of $59.80.
The stock price for Insmed (NASDAQ: INSM) is $67 last updated June 28, 2024 at 4:50 PM EDT.
There are no upcoming dividends for Insmed.
Insmed’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.